US 7790878
RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof
granted A61KA61K31/7088A61P
Quick answer
US patent 7790878 (RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/7088, A61P, A61P11/00, A61P31/12